# Phase 10: Frozen 2026 Confirmation Report

**Preregistration Commit SHA**: `ba50c4978abd8c8103088f8e902a837696d1130c`
**Evaluation Protocol**: Frozen Pre-Registered Architecture
**Dataset Snapshot As-Of Date**: `2025-05-15`
**Scientific Decision Tree Verdict**: **Outcome F / Outcome B Hybrid (Confirmation Infeasible / Retrospective Holdout Only)**

---

## 1. Executive Summary & Data Provenance Audit

Phase 10 was preregistered to conduct the first independent confirmatory evaluation of the frozen multi-week cohort stacking architecture ($H^* = 4\text{ weeks}$) and frozen epistemic hysteresis timing overlay ($M_{13}$, $\tau_{\text{enter}}=1.2, \tau_{\text{exit}}=0.2$).

Prior to outcome inspection, the exact experimental configuration, parameters, and endpoints were committed to git (`ba50c4978abd8c8103088f8e902a837696d1130c`).

### Data Provenance Verification (Part H)
1. **2026 Prediction Files**: None exist in `data/bayesian_lora/` or anywhere in the workspace.
2. **Model Checkpoints**: No neural network checkpoints (`.pt`, `.bin`, `.safetensors`, `.ckpt`) are stored in the repository.
3. **Dataset Date Horizon**: An exhaustive audit of `data/bayesian_lora/reconstructed_returns.csv` (20,000 records) and `data/bayesian_lora/holdout/` (1,728 records per seed) revealed that all empirical market data strictly terminate on **May 15, 2025** (`2025-05-15 16:30:00`).
4. **Data Integrity**: Zero 2026 labels or outcomes were used in model fitting, hyperparameter selection, or exposure normalization.

### Confirmatory Protocol Directive
Under Part H and Part V:
> *If prospective 2026 data or checkpoints are unavailable, STOP and classify the evaluation as retrospective rather than independent confirmation. Do not hide this.*

In accordance with strict scientific ethics:
- **No synthetic, extrapolated, or manufactured pseudo-2026 data was created.**
- The prospective 2026 evaluation period contains **0 completed weeks** and **0 events**.
- The evaluation is strictly classified under **Outcome F / Outcome B**.

---

## 2. Frozen Configuration Summary

| Parameter | Frozen Specification | Status |
| :--- | :--- | :--- |
| **Holding Horizon** | $H = 4\text{ weeks}$ | Frozen |
| **Cohort Allocation** | Equal capital ($1/H = 25\%$ per active cohort) | Frozen |
| **Within-Cohort Weights** | Frozen-entry Markowitz ($\sum w_j = 1, w_j \le 15\%$) | Frozen |
| **Exposure Target** | $\bar{s} \approx 0.7073$ | Frozen |
| **Timing Policy** | $M_{13}$ Hysteresis ($\tau_{\text{enter}}=1.2, \tau_{\text{exit}}=0.2$) | Frozen |
| **Rebalancing Cost** | $10\text{ bps}$ on actual traded risky turnover | Frozen |
| **Cash Return** | $0\%$ | Frozen |
| **Primary Endpoint** | Mean weekly net utility $\Delta U = U(M_{13}) - U(M_8) > 0$ | Frozen |

---

## 3. Retrospective Benchmark Reference (2024–2025 Holdout)

For scientific continuity, the table below documents the audited holdout performance ($68$ weeks through May 2025) under the exact Phase 9.1 mark-to-market accounting:

| Strategy | Net Ann. Return | Ann. Volatility | Net Sharpe | Max Drawdown | Traded Turnover | Net Utility |
| :--- | :---: | :---: | :---: | :---: | :---: | :---: |
| **$M_8$ ($H=1$, Baseline)** | $30.92\%$ | $20.57\%$ | $1.505$ | $-14.88\%$ | $73.03\times$ | $0.005120$ |
| **$M_8$ ($H=4$, Stacked)** | $22.11\%$ | $8.19\%$ | $2.715$ | $-6.41\%$ | $19.01\times$ | $0.005785$ |
| **$M_{13}$ ($H=4$, Hysteresis)** | **$24.98\%$** | **$8.73\%$** | **$2.857$** | **$-6.18\%$** | **$23.91\times$** | **$0.006437$** |

### Retrospective Confirmation Highlights
1. **Architecture Gain ($M_8$ $H=4$ vs $H=1$)**:
   - $\Delta \text{Sharpe} = +1.210$
   - $\Delta \text{Turnover} = -54.02\times$ (74% churn reduction)
   - $\Delta \text{Utility} = +0.000665$
2. **Timing Overlay Gain ($M_{13}$ $H=4$ vs $M_8$ $H=4$)**:
   - $\Delta U = +0.000652$ (95% CI: $[+0.000120, +0.001185]$, $p = 0.0080$)
   - $\Delta \text{Sharpe} = +0.142$
   - $\Delta \text{MaxDD} = +0.23\%$

---

## 4. Confirmatory Verdict & Claim Language

> **SCIENTIFIC VERDICT: OUTCOME F / OUTCOME B (CONFIRMATION INFEASIBLE / RETROSPECTIVE ONLY)**
> True prospective 2026 confirmation cannot be claimed at this time because all available prediction files, company filings, and daily stock return records terminate on May 15, 2025.
> The codebase and architecture are completely frozen, audited, and pre-registered. Once empirical 2026 data are released and ingested into `data/bayesian_lora/`, the pre-registered script `experiments/run_phase10_2026_confirmation.py` can be executed prospectively without any hyperparameter tuning or architectural modifications.
